v3.23.1
Condensed Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 3,723 $ 4,391
Short-term marketable securities 2,049
Prepaid expenses and other current assets 592 825
Deferred offering costs 246
Total assets 4,561 7,265
Current liabilities:    
Accounts payable 828 534
Accrued expenses 477 568
Total liabilities 1,305 1,102
Commitments and contingencies
Stockholders’ equity:    
Convertible preferred stock, $0.0001 par value; 15,000,000 shares authorized as of March 31, 2023, and December 31, 2022, respectively; none shares issued and outstanding at March 31, 2023, and December 31, 2022
Common stock, $0.0001 par value, 250,000,000 shares authorized at March 31, 2023, and December 31, 2022; 9,131,248 and 9,097,701 shares issued and outstanding as of March 31, 2023, and December 31, 2022, respectively 1 1
Additional paid-in capital 37,685 37,318
Accumulated other comprehensive income 17
Accumulated deficit (34,430) (31,173)
Total stockholders’ equity 3,256 6,163
Total liabilities and stockholders’ equity $ 4,561 $ 7,265

Source